Main > ONCOLOGY (**) > Lung>NSCLC>MET>PD-L1>High+ > TREAT.: > USA. G. AterolizuMAb Inj. IV Use

---

USA. G. AterolizuMAb Inj. IV Use's subsections
(*) USA Approval Date: 2020. 05.18.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 09.22.
TradeMark
TradeMark Web-Site

USA. G. AterolizuMAb Inj. IV Use's products
This section has no products